Hostname: page-component-7c8c6479df-5xszh Total loading time: 0 Render date: 2024-03-29T12:09:43.648Z Has data issue: false hasContentIssue false

Moderately elevated preconception fasting plasma total homocysteine is a risk factor for psychological problems in childhood

Published online by Cambridge University Press:  14 January 2019

Joana Roigé-Castellví
Affiliation:
Department of Psychology, Universitat Rovira I Virgili, Carretera de Valls s/n, 43007Tarragona, Spain Research Center for Behavioral Assessment (CRAMC), Universitat Rovira i Virgili, Tarragona, Spain
Michelle Murphy
Affiliation:
Department of Basic Medical Sciences, Universitat Rovira i Virgili and IISPV, Reus, Spain Biomedical Research Networking Center for the Pathophysiology of Obesity, Carlos III Institute of Health, Madrid, Spain
Joan Fernández-Ballart
Affiliation:
Department of Basic Medical Sciences, Universitat Rovira i Virgili and IISPV, Reus, Spain Biomedical Research Networking Center for the Pathophysiology of Obesity, Carlos III Institute of Health, Madrid, Spain
Josefa Canals*
Affiliation:
Department of Psychology, Universitat Rovira I Virgili, Carretera de Valls s/n, 43007Tarragona, Spain Research Center for Behavioral Assessment (CRAMC), Universitat Rovira i Virgili, Tarragona, Spain
*
*Corresponding author: Email josefa.canals@urv.cat
Rights & Permissions [Opens in a new window]

Abstract

Objective

We investigated the effect of maternal preconception fasting plasma total homocysteine (tHcy) on psychological problems in children aged 6 years from normal pregnancies.

Design

A longitudinal study was carried out from preconception, throughout each trimester of pregnancy, until 6 years of age in the offspring. Fasting blood samples at 2–10 weeks preconception and non-fasting samples at birth were collected. Parents completed the Child Behaviour Checklist (CBCL) and teachers the Inattention-Overactivity with Aggression (IOWA) scale for the 6-year-old children.

Setting

Elevated tHcy during pregnancy has been associated with several adverse outcomes and with neurodevelopmental impairment in the offspring.

Participants

The initial sample consisted of 139 healthy non-pregnant women who were planning on becoming pregnant. Eighty-one mother–child dyads were followed from preconception until 6 years of age.

Results

After adjusting for covariables, multiple linear regression models showed that higher preconception tHcy was associated with higher scores in internalizing dimension (β=0·289; P=0.028), specifically in withdrawn behaviour (β=0·349; P=0·009), anxiety/depression (β=0·303; P=0·019) and social problems (β=0·372; P=0·009). Aggressive behaviour in the school setting was higher in children whose mothers had higher preconception tHcy (β=0·351; P=0·014).

Conclusions

Moderately elevated preconception tHcy may increase the risk of psychological problems in offspring during childhood. These findings add to the evidence that maternal nutritional status, even before being pregnant, can affect later offspring health and may be important to consider when developing future public health policy.

Type
Research paper
Copyright
© The Authors 2019 

The one-carbon metabolic network plays a crucial role in cellular metabolism and proliferation and affects reproductive and pregnancy outcomes, as well as the future health of the offspring( Reference Kalhan 1 ). The metabolic network is essential for DNA synthesis and repair, as well as for providing methyl groups for epigenetic regulatory processes. Fasting plasma total homocysteine (tHcy) is a useful biomarker of the network. Homocysteine (Hcy) is an intermediate in the network, and folate, vitamins B12 and B6, as well as other micronutrients, participate in its metabolism( Reference Selhub 2 ). Plasma tHcy acts as a global indicator of status in folate and vitamin B12 ( Reference Brustolin, Giugliani and Félix 3 ).

Accumulation of Hcy in nerve cells acts as a potentially toxic substance for the nervous system because it promotes excitotoxicity and damages neuronal DNA, which may lead to neuroanatomical disturbances( Reference Douaud, Refsum and de Jager 4 ), cognitive impairment and several neurodegenerative disorders in the elderly( Reference Haan, Miller and Aiello 5 Reference Seshadri, Beiser and Selhub 7 ). Elevated pregnancy tHcy is a strong and independent risk factor for adverse outcomes in the offspring such as neural tube defects( Reference Tang, Li and Wang 8 ), low birth weight( Reference Bergen, Jaddoe and Timmermans 9 , Reference Murphy, Scott and Arija 10 ) and congenital heart defects( Reference Verkleij-Hagoort, Bliek and Sayed-Tabatabaei 11 ). Supplementing mothers with 400 µg folic acid daily is widely recommended from periconception throughout the first trimester to prevent adverse effects of folate deficiency on fetal development( Reference Berti, Biesalski and Gärtner 12 , Reference Blumfield, Hure and Macdonald-wicks 13 ). Folic acid supplementation is one of the factors that contributes to lowering of tHcy during pregnancy( Reference Murphy, Scott and McPartlin 14 , Reference McNulty, McNulty and Marshall 15 ).

In terms of neurodevelopment, Murphy et al. ( Reference Murphy, Fernandez-Ballart and Molloy 16 ) reported that moderately elevated preconception tHcy (>9·0 µmol/l) was associated with greater probabilities of lower psychomotor ability (Bayley Scale of Infant Development) in 4-month-old infants and worse cognitive performance in 6-year-old children (Wechsler Preschool and Primary Scale of Intelligence). Additionally, Ars et al. ( Reference Ars, Nijs and Marroun 17 ) reported that elevated maternal tHcy (>9·1 µmol/l) in early pregnancy (mean gestational age 13·5 weeks) was associated with worse performance in language and visuo-spatial cognitive domains in children between 6 and 8 years of age. Likewise, pregnancy status of other micronutrients involved in one-carbon metabolism (B vitamins principally) has been associated with improved child cognitive performance as well as behavioural outcomes in school-aged children( Reference Anjos, Altmäe and Emmett 18 ).

Regarding behavioural problems, maternal tHcy is also related to long-term emotional disturbances and peer problems in children( Reference Schlotz, Jones and Phillips 19 ). It has been suggested that periconception folic acid supplement use may protect against behavioural problems( Reference Roza, van Batenburg-Eddes and Steegers 20 ) and neurodevelopmental disorders such as autism spectrum disorders (ASD) in offspring( Reference DeVilbiss, Gardner and Newschaffer 21 Reference Surén, Roth and Bresnahan 23 ). Despite this evidence, some studies did not corroborate the adverse effects of high tHcy from 4 weeks prior and through to 8 weeks after the last menstrual period (by three 4-week periods) or low folate status on behavioural problems in the offspring( Reference Virk, Liew and Olsen 24 ). In fact, recent studies even reported that high maternal intake of folic acid (≥1000 μg/d) during pregnancy (10–13 and 28–32 gestational weeks) could have a damaging effect on neurodevelopment in the offspring at 4–5 years of age( Reference Boyles, Yetley and Thayer 25 , Reference Valera-Gran, Navarrete-Muñoz and Garcia de la Hera 26 ). Furthermore, in an ongoing prospective birth cohort study on early-life determinants of autism (the Boston Birth Cohort co-led by the Center on the Early Life Origins of Diseases), pregnancy tHcy did not predict the offspring’s ASD risk, but this risk was highest in children whose mothers had very high blood folate level (>59 nmol/l) and vitamin B12 (>600 pmol/l) right after giving birth. Mandatory fortification of flour in the USA with folic acid has been in place since 1998 and numerous countries have since implemented the same policy. The debate regarding the benefit of prenatal folic acid supplementation to child health is growing in this context. Other authors( Reference Selhub and Rosenberg 27 ) report that excessive intake from supplementation combined with fortification may have detrimental effects on child health. In European countries, there is no mandatory fortification and although voluntary fortification is present in many countries, folate status of the general population is generally relatively low compared with those where mandatory fortification is in place( Reference Bueno, Molloy and Fernandez-Ballart 28 ). Additionally, variation in the genes regulating nutrient status may indirectly affect maternal-to-infant nutrient transfer( Reference Selhub and Rosenberg 27 ).

To the best of our knowledge, no previous study has investigated whether preconception tHcy affects psychological problems in the children. We hypothesized that moderately elevated preconception tHcy is associated with behavioural and emotional problems in the offspring in mid-childhood. The aim of the present study was to investigate the effect of maternal tHcy measured 2–10 weeks before conception on psychological problems in children aged 6 years from uncomplicated pregnancies.

Materials and methods

Study population

The longitudinal preconception study was carried out from before conception (2–10 weeks before pregnancy), throughout each trimester of pregnancy, until 6 years of age in the offspring. The study design( Reference Murphy, Scott and McPartlin 14 ) and data from the children at 6 years have been reported previously( Reference Canals, Esparó and Fernandez-Ballart 29 ).

Participants in the preconception phase of the study were healthy non-pregnant women aged 18–35 years who were planning on becoming pregnant. Recruitment was carried out by the Unit of Preventive Medicine and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili in collaboration with the Unit of Obstetrics and Gynaecology, Sant Joan University Hospital Reus. The psychological assessment was performed by the Department of Psychology.

The study was approved by St. Joan Hospital’s (Reus) Ethics Committee and signed informed consent was obtained from all participating volunteers.

Briefly, during the preconception phase 139 women volunteered to participate in the study. After application of the exclusion criteria such as the presence of chronic illness affecting nutritional status, infertility, failure to conceive or miscarriage after entering the study, ninety-two women went on to complete successful pregnancies with complete mother–newborn dyad information available. Of these, eighty-one agreed to participate in the follow-up phase in the mothers and children aged 6 years. The study design is shown in Fig. 1.

Fig. 1 Flowchart showing the number of participants throughout the study (PreC, preconception; STAI; State-Trait Anxiety Inventory; tHcy, total homocysteine; CBCL/4-18, Child Behaviour Checklist; IOWA, Inattention-Overactivity with Aggression; IQ, intelligence quotient; WPPSI, Wechsler Preschool and Primary Scale of Intelligence)

At the time of the study, recommendation of periconception folic acid supplement use was not protocol in Spain. Coinciding with Fe supplementation in mid-late pregnancy, some women took multivitamin supplements.

Blood sample collection and analyses of total homocysteine

Fasting blood samples from the antecubital vein were collected into EDTA-K3 vacutainers between days 7 and 14 of the menstrual cycle. If participants did not become pregnant within three menstrual periods after the first preconception blood sample, another sample was taken until becoming pregnant. Similarly, blood samples were taken at 7·5–8 gestational weeks (between 53 and 59 d after the first day of their last menstrual period), 20 and 32 gestational weeks and on admission to hospital with confirmed labour.

Blood samples were kept refrigerated and plasma was separated by centrifugation strictly within less than 2 h of collection. Plasma from the pregnancy phase was stored at −20ºC and from the follow-up phase at −70ºC before tHcy determination using the IMx homocysteine immunoassay (Abbott Laboratories Diagnostics Division, Abbott Park, IL, USA). A more detailed description of sample collection and analysis has been reported previously( Reference Murphy, Scott and McPartlin 14 ).

Assessment of psychological problems

The Child Behaviour Checklist (CBCL/4-18)( Reference Achenbach 30 ) is an extensively used report form to identify emotional and behaviour problems in children. It is a questionnaire consisting of 118 items, completed by parents, regarding their children’s psychological problems. This instrument has nine syndrome scales (withdrawn, anxious/depressed, somatic complaints, social problems, thought problems, attention problems, delinquent behaviour, aggressive behaviour and sex problems); two dimension scales (internalizing dimension, consisting of withdrawn, somatic complaints and anxious/depressed syndromes; and externalizing dimension, consisting of delinquent behaviour and aggressive behaviour); and the total psychological problems scale. In the present study, we applied a Catalan version of this test (Cronbach’s α coefficient ranged from 0·60 to 0·87), using the T-score for multicultural data.

To evaluate child behaviour based on teacher responses, we used the Inattention-Overactivity with Aggression (IOWA) Conners’ Teachers’ rating scale( Reference Loney and Milich 31 ). IOWA is a behavioural rating scale with ten items (which range from ‘not all’ until ‘very much’) divided into two scales: aggressive behaviour and hyperactivity. We used a Catalan version adapted for the present study, which had an adequate internal consistency (Cronbach’s α ranged from 0·84 to 0·80).

Covariates

Maternal anxiety was assessed at preconception, at each trimester of pregnancy, and at 3 d and 1 month postpartum using the State-Trait Anxiety Inventory (STAI)( Reference Spielberger, Gorsuch and Lushene 32 ). For the analyses of the current study, we used the trait anxiety mean score from all assessments.

Smoking habits were recorded in periodic interviews carried out from preconception throughout pregnancy.

Data regarding medication and/or vitamin supplement use as well as sociodemographic parameters including parental education were also recorded in these interviews. None of the women took supplements before mid-pregnancy.

The total intelligence quotient (IQ) of the children at 6 years was assessed by the Wechsler Preschool and Primary Scale of Intelligence (WPPSI)( Reference Wechsler 33 ). WPPSI is an individually administered IQ test and consists of ten sub-tests which form the verbal and manipulative index, the sum of which gives the total IQ.

We also included birth weight and child BMI at 6 years in the models exploring the relationship between preconception tHcy and psychological outcomes in the children.

Statistical analyses

To explore the relationship between preconception tHcy and psychological problems of offspring in childhood, we stratified preconception tHcy into tertiles. The highest tertile was designated as the moderately elevated group while the middle and lowest tertiles were designated as normal. Student’s unpaired t tests and χ 2 analyses were used to compare the sociodemographic and child characteristics for each subscale of the CBCL/4-18 and IOWA tests between the tHcy groups.

To investigate the effect of maternal preconception tHcy on psychological problems, unadjusted linear regressions were performed for each subscale. Then, we performed the same multiple linear regressions including covariates (by the enter method) in separate models. The covariates included were birth weight, parental education (combined both maternal and parental), smoking during pregnancy, maternal trait anxiety during pregnancy (the mean score at different times of pregnancy), maternal tHcy at labour, and BMI and total IQ of children at age 6 years. Child sex and maternal multivitamin supplement use during the second and third trimesters were also tested in the models, but they were not significantly associated with any of the dependent variables and so were not included in the models in order to maintain an acceptable proportion of covariates per case.

All statistical analyses were performed with the statistical software package IBM SPSS Statistics version 23.

Results

Descriptive preconception and childhood data are reported in Table 1. At preconception, mean maternal age was 29·6 years and mean tHcy was 8·53 µmol/l. Thirty per cent of the women were smokers during pregnancy. Regarding the children, forty were boys and forty-one were girls and mean birth weight was 3247·90 g (ranging from 1950 g to 4690g). At age 6 years, mean BMI was 17·30 kg/m2 (ranging from 13·55 to 24·94 kg/m2). The mean total IQ (WPPSI) was normal–high (116·33; ranging from 83 to 144). Moderately elevated and normal preconception tHcy groups were created based on tHcy in the highest tertile (≥9·04 µmol/l; n 24) or below this (n 52), respectively. Differences in maternal and child characteristics between tHcy groups are shown in Table 1. We found a significantly higher frequency of both multiparous women and males in the normal tHcy group compared with the moderately elevated tHcy group.

Table 1 Mother and child characteristics from the preconception to follow-up stage and differences between maternal preconception total homocysteine groups (PreConception Study, pregnancy phase 1992–1996; child follow-up stage 1998–2002. Reus, Spain)

PreC, preconception; tHcy, total homocysteine; IQ, intelligence quotient.

* Fasting plasma tHcy is geometric mean.

Mean of State-Trait Anxiety Inventory scores from PreC to immediate postpartum.

Wechsler Preschool and Primary Scale of Intelligence.

§ t Test: mean, sd and t value.

χ 2 Test: %, n and χ 2 value.

CBCL/4-18 and IOWA scores according to maternal preconception tHcy category are reported in Table 2. The mean scores for CBCL/4-18 total, internalizing and externalizing problems were within the normal range (54·33, 54·21 and 54·45, respectively). Several mean scores were higher in children born to mothers with moderately elevated preconception tHcy compared with those born to mothers with normal preconception tHcy, although these differences were not significantly different between the groups.

Table 2 Comparison of child psychological problems at age 6 years between maternal preconception total homocysteine groups (PreConception Study, pregnancy phase 1992–1996; child follow-up stage 1998–2002. Reus, Spain)

tHcy, total homocysteine; CBCL/4-18, Child Behaviour Checklist; IOWA, Inattention-Overactivity with Aggression.

Homogeneity of variances were assumed for all the subscales.

CBCL/4-18 subscales, df=73; IOWA subscales, df=74.

*t Test: t value.

Table 3 shows the significant multiple linear regression models of the effect of preconception tHcy on behaviour and emotional problems of children at 6 years of age. In unadjusted models, children of mothers with moderately elevated preconception tHcy had significantly higher scores on CBCL/4-18 subscales for withdrawn (corrected R 2=11·6; P=0·002), social problems (corrected R 2=6·6; P=0·016) and aggressive behaviour (corrected R 2=4·7; P=0·037).

Table 3 Significant multiple linear regression models of the effect of maternal preconception total homocysteine level on child psychological problems at age 6 years (PreConception Study, pregnancy phase 1992–1996; child follow-up stage 1998–2002. Reus, Spain)

cR 2, corrected R 2; PreC, preconception; tHcy, total homocysteine; CBCL/4-18, Child Behaviour Checklist; IOWA, Inattention-Overactivity with Aggression; STAI, State-Trait Anxiety Inventory; IQ, intelligence quotient; WPPSI, Wechsler Preschool and Primary Scale of Intelligence.

Adjusted models include the following covariates (enter method): birth weight (g), BMI (kg/m2) at age 6 years, parental education (combined both maternal and paternal), smoking during pregnancy, mean of anxiety during pregnancy (STAI), total IQ at age 6 years (WPPSI) and maternal tHcy at birth.

In adjusted models, more subscales were observed to be significantly associated with preconception tHcy. These models showed that preconception tHcy was positively associated with withdrawn behaviour (β=0·349, P=0·009), anxiety/depression (β=0·303, P=0·019), social problems (β=0·372, P=0·009) and internalizing dimension (β=0·289, P=0·028) in CBCL/4-18, always jointly with maternal anxiety. In IOWA subscales, we found that aggressive behaviour was significantly higher in children from mothers who had moderately elevated preconception tHcy (β=0·351, P=0·014; see Table 3).

Discussion

The aim of the present study was to investigate the association between maternal preconception tHcy and psychological problems in offspring in a long-term prospective study. To test our hypothesis, we first performed comparisons between groups based on tertile of maternal preconception tHcy. So, the moderately elevated tHcy category was composed of the highest tertile (≥9·04 µmol/l) and compared with the normal group (middle and lowest tertiles). This cut-off for the highest tertile tHcy is similar to that reported for women aged 18–35 years, non-users of vitamin B supplements (≥9·55 µmol/l), from the same geographical area( Reference Murphy, Vilella and Ceruelo 34 ). Murphy et al. previously reported in this same cohort of mothers and children that plasma folate tended to be lower in mothers with moderately elevated tHcy compared with those with normal tHcy at various time points as well as in the child. No differences in plasma cobalamin were observed between the two groups( Reference Murphy, Fernandez-Ballart and Molloy 16 ). On the other hand, mandatory folic acid fortification is absent in Spain and the plasma folate concentrations reported in Murphy et al.’s study( Reference Murphy, Fernandez-Ballart and Molloy 16 ) show that the cohort was relatively free of exposure to high folic acid intake due to supplement use and/or mandatory folic acid fortification.

Regarding comparison between tHcy groups, the analyses did not show any significant results, only a tendency for higher score in withdrawn behaviour was observed in the highest tertile. However, both adjusted and non-adjusted models showed that children born to mothers with higher tHcy concentrations at preconception scored higher for withdrawn and social problems. In the adjusted models, CBCL/4-18 anxiety/depression scale and IOWA aggressive behaviour were additionally predicted by preconception tHcy. From the point of view of neurological maturity, social behaviour is related with many brain regions and neural circuits which begin their development in the period of early corticogenesis. In mice, Belinson et al. ( Reference Belinson, Nakatani and Babineau 35 ) demonstrated a fetal origin for social and repetitive behaviour deficits seen in disorders such as ASD. Considering that the manifestations of withdrawn and social problems are, among others, typical clinical symptoms of ASD, the observed association between these manifestations and tHcy could support the preventive role of prenatal folic acid in the onset of ASD found by other authors( Reference Wang, Li and Zhao 36 , Reference Raghavan, Riley and Volk 37 ). However, in our study no diagnostic assessment of ASD was performed, and the withdrawn and social problems could also be symptoms of other disorders such as emotional disorders. In contrast, recent studies have not been able to substantiate a beneficial effect on child risk of ASD by maternal folic acid supplementation in the periconceptional period( Reference Strøm, Granström and Lyall 38 ). High maternal plasma folate at birth was not associated with reduced ASD risk either( Reference DeVilbiss, Magnusson and Gardner 39 , Reference Zhou, Liu and He 40 ). Recently, Raghavan et al. ( Reference Raghavan, Riley and Volk 37 ) reported a U-shaped relationship between folate and B12 levels and ASD risk. On the other hand, regardless of the level of maternal Hcy and folate, some authors suggest that children with ASD may have defects in folic acid absorption that play a role in the onset of ASD( Reference Zhou, Liu and He 40 ). Regarding the relationship found between anxiety/depression problems (and internalizing dimension) and higher preconception tHcy, our data are comparable to the results of other authors( Reference Wang, Li and Zhao 36 , Reference Steenweg-De-Graaff, Roza and Steegers 41 ). Steenweg-De-Graaff et al. ( Reference Steenweg-De-Graaff, Roza and Steegers 41 ) found a higher risk of emotional problems in children of mothers who started using folic acid supplements late or did not use supplements at all than in children whose mothers started periconceptionally. In our study, also the women started supplementation after mid-pregnancy, which supports the idea that the protective role of folic acid on neurodevelopment of the child is in very early pregnancy. Steenweg-De-Graaff et al. ( Reference Steenweg-De-Graaff, Roza and Steegers 41 ) did not find a relationship between prenatal folate deficiency and behaviour problems in the offspring, in contrast to findings of the present study showing an association between preconception tHcy and aggressive behaviours. Although aggressiveness is an externalizing manifestation, in the clinical setting it is not infrequent to find that children express their emotional distress with irritability and aggressive behaviour.

It is relevant to remark that preconception tHcy was associated with higher psychological problem scores regardless of maternal tHcy at birth, supporting the importance in neurodevelopment of optimal tHcy in early pregnancy. In this sense, other researchers did not find significant associations between mid–late pregnancy tHcy concentrations and childhood cognitive functions( Reference Veena, Krishnaveni and Srinivasan 42 ) or neurodevelopment( Reference Tamura, Goldenberg and Chapman 43 ).

Our study confirms the relevance of considering preconception tHcy. The strength of the study is the precise timing of preconception tHcy measurements from mothers, which were performed within 2–10 weeks of becoming pregnant and in a specific window of the preconception menstrual cycle (specifically during the periovulation phase between days 7 and 12). In this way, it was ensured that the preconception blood sample reflected the habitual maternal tHcy levels, because tHcy normally decreases rapidly during the first half of the pregnancy period( Reference Murphy, Scott and McPartlin 14 ). Therefore, the preconception tHcy sample is free of the physiological effects of pregnancy that affect tHcy concentrations. The strong and innovative aspect of the study lies in its design from preconception throughout childhood and that we were extremely careful to optimize the precision of tHcy determinations as near as possible to neurogenesis in the embryo. Furthermore, extensive and accurate lifestyle and clinical data were also collected before pregnancy. We were also able to adjust our analysis for late pregnancy tHcy and the sample was homogeneous with respect to the absence of variables which could be risk factors of psychological problems. Several important confounders have been taken into account in the regression models, and prenatal anxiety was a significant predictor of child psychopathological characteristics as previously reported( Reference Glover 44 ).

The small sample size was due to the difficulty in recruiting women at preconception and the commitment to planning determinations from preconception throughout pregnancy and subsequently in the follow-up phase in the child at 6 years after birth. Given that the study followed prospectively a cohort of pregnant women without specific risk factors, we were not inclined to consider the assessment of possible psychopathological diagnoses in this group and this was a potential limitation.

Conclusion

We conclude that moderately elevated preconception tHcy is associated with increased risk of psychological problems in the offspring, especially of internalizing problems and social problems, although also of aggressive behaviour. Further research is needed to corroborate the role of prenatal tHcy in neuropsychiatric disorders.

Acknowledgements

Acknowledgements: The biochemical determinations were carried out in Professor Anne Molloy’s lab in Trinity College Dublin. Financial support: This study was supported financially by the Comisión Interministerial de Ciencia y Tecnología (grant number CICYT: ALI 89-0388), Fondo de Investigación Sanitaria (grant number FIS:00/0954) and Instituto de Salud Carlos III, Red de Centros en Metabolismo y Nutrición, Madrid, Spain (grant number C03/08). The funders had no role in the design, analysis or writing of this article. Conflict of interest: The authors report no conflicts of interest. Authorship: M.M., J.F.-B. and J.C. participated in hypothesis development and designing the study. J.R.-C. was primarily responsible for data analysis and the writing of the paper. All authors revised and approved the final version of the paper. Ethics of human subject participation: This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects were approved by the St. Joan Hospital’s (Reus) Ethics Committee. Written informed consent was obtained from all participating volunteers.

References

1. Kalhan, SC (2016) One carbon metabolism in pregnancy: impact on maternal, fetal and neonatal health. Mol Cell Endocrinol 435, 4860.Google Scholar
2. Selhub, J (2008) Public health significance of elevated homocysteine. Food Nutr Bull 29, 116125.Google Scholar
3. Brustolin, S, Giugliani, R & Félix, TM (2010) Genetics of homocysteine metabolism and associated disorders. Braz J Med Biol Res 43, 17.Google Scholar
4. Douaud, G, Refsum, H, de Jager, C et al. (2013) Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A 110, 95239528.Google Scholar
5. Haan, MN, Miller, JW, Aiello, AE et al. (2007) Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 85, 511517.Google Scholar
6. Mattson, MP & Shea, TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26, 137146.Google Scholar
7. Seshadri, S, Beiser, A, Selhub, J et al. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 346, 476483.Google Scholar
8. Tang, K-F, Li, Y-L & Wang, H-Y (2015) Quantitative assessment of maternal biomarkers related to one-carbon metabolism and neural tube defects. Sci Rep 5, 8510.Google Scholar
9. Bergen, NE, Jaddoe, VW, Timmermans, S et al. (2012) Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the Generation R Study. BJOG 119, 739751.Google Scholar
10. Murphy, MM, Scott, JM, Arija, V et al. (2004) Maternal homocysteine before conception and throughout pregnancy predicts fetal homocysteine and birth weight. Clin Chem 50, 14061412.Google Scholar
11. Verkleij-Hagoort, A, Bliek, J, Sayed-Tabatabaei, F et al. (2007) Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis. Am J Med Genet A 143A, 952960.Google Scholar
12. Berti, C, Biesalski, HK, Gärtner, R et al. (2011) Micronutrients in pregnancy: current knowledge and unresolved questions. Clin Nutr 30, 689701.Google Scholar
13. Blumfield, ML, Hure, AJ, Macdonald-wicks, L et al. (2013) Micronutrient intakes during pregnancy in developed countries: systematic review and meta-analysis. Nutr Rev 71, 118132.Google Scholar
14. Murphy, MM, Scott, JM, McPartlin, JM et al. (2002) The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study. Am J Clin Nutr 76, 614619.Google Scholar
15. McNulty, B, McNulty, H, Marshall, B et al. (2013) Impact of continuing folic acid after the first trimester of pregnancy: findings of a randomized trial of folic acid supplementation in the second and third trimesters. Am J Clin Nutr 98, 9298.Google Scholar
16. Murphy, MM, Fernandez-Ballart, JD, Molloy, AM et al. (2017) Moderately elevated maternal homocysteine at preconception is inversely associated with cognitive performance in children 4 months and 6 years after birth. Matern Child Nutr 13, e12289.Google Scholar
17. Ars, CL, Nijs, IM, Marroun, HE, et al. (2016) Prenatal folate, homocysteine and vitamin B12 levels and child brain volumes, cognitive development and psychological functioning: the Generation R Study. Br J Nutr. Published online: 22 January 2016. doi: 10.1017/S0007114515002081.Google Scholar
18. Anjos, T, Altmäe, S, Emmett, P et al. (2013) Nutrition and neurodevelopment in children: Focus on NUTRIMENTHE project. Eur J Nutr 52, 18251842.Google Scholar
19. Schlotz, W, Jones, A, Phillips, DIW et al. (2010) Lower maternal folate status in early pregnancy is associated with childhood hyperactivity and peer problems in offspring. J Child Psychol Psychiatry 51, 594602.Google Scholar
20. Roza, SJ, van Batenburg-Eddes, T, Steegers, E a P et al. (2010) Maternal folic acid supplement use in early pregnancy and child behavioural problems: the Generation R Study. Br J Nutr 103, 445452.Google Scholar
21. DeVilbiss, EA, Gardner, RM, Newschaffer, CJ et al. (2015) Maternal folate status as a risk factor for autism spectrum disorders: a review of existing evidence. Br J Nutr 114, 663672.Google Scholar
22. Schmidt, RJ, Tancredi, DJ, Ozonoff, S et al. (2012) Maternal periconceptional folic acid intake and risk for developmental delay and autism spectrum disorder: a case–control study. Am J Clin Nutr 96, 8089.Google Scholar
23. Surén, P, Roth, C, Bresnahan, M et al. (2013) Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA 309, 570577.Google Scholar
24. Virk, J, Liew, Z, Olsen, J et al. (2015) Preconceptional and prenatal supplementary folic acid and multivitamin intake and autism spectrum disorders. Autism 20, 710718.Google Scholar
25. Boyles, AL, Yetley, EA, Thayer, KA et al. (2016) Safe use of high intakes of folic acid: research challenges and paths forward. Nutr Rev 74, 469474.Google Scholar
26. Valera-Gran, D, Navarrete-Muñoz, EM, Garcia de la Hera, M et al. (2017) Effect of maternal high dosages of folic acid supplements on neurocognitive development in children at 4–5 years of age: the prospective birth cohort Infancia y Medio Ambiente (INMA) study. Am J Clin Nutr 106, 878887.Google Scholar
27. Selhub, J & Rosenberg, IH (2016) Excessive folic acid intake and relation to adverse health outcome. Biochimie 126, 7178.Google Scholar
28. Bueno, O, Molloy, AM, Fernandez-Ballart, JD et al. (2016) Common polymorphisms that affect folate transport or metabolism modify the effect of the MTHFR 677C>T polymorphism on folate status. J Nutr 146, 18.T+polymorphism+on+folate+status.+J+Nutr+146,+1–8.>Google Scholar
29. Canals, J, Esparó, G & Fernandez-Ballart, J (2006) Neonatal behaviour characteristics and psychological problems at 6 years. Acta Paediatr 95, 14121417.Google Scholar
30. Achenbach, TM (1991) Manual for the Child Behavior Checklist (4–18 and 1991 profile). Burlington, VT: University of Vermont.Google Scholar
31. Loney, J & Milich, R (1982) Hyperactivity, inattention and aggression in clinical practice. Adv Dev Behav Pediatr 3, 113232.Google Scholar
32. Spielberger, CD, Gorsuch, RL & Lushene, RE (1988) Cuestionario de Ansiedad Estado-Rasgo. Manual de Adaptación Española. Madrid: TEA Ediciones.Google Scholar
33. Wechsler, D (1996) Escala de Inteligencia de Wechsler para Preescolar y Primaria, WIPPSI. Manual de Adaptación Española. Madrid: TEA Ediciones.Google Scholar
34. Murphy, MM, Vilella, E, Ceruelo, S et al. (2002) The MTHFR C677T, APOE, and PON55 gene polymorphisms show relevant interactions with cardiovascular risk factors. Clin Chem 48, 372375.Google Scholar
35. Belinson, H, Nakatani, J, Babineau, BA et al. (2016) Prenatal β-catenin/Brn2/Tbr2 transcriptional cascade regulates adult social and stereotypic behaviors. Mol Psychiatry 21, 14171433.Google Scholar
36. Wang, M, Li, K, Zhao, D et al. (2017) The association between maternal use of folic acid supplements during pregnancy and risk of autism spectrum disorders in children: a meta-analysis. Mol Autism 8, 51.Google Scholar
37. Raghavan, R, Riley, AW, Volk, H et al. (2017) Maternal multivitamin intake, plasma folate and vitamin B12 levels and autism spectrum disorder risk in offspring. Paediatr Perinat Epidemiol 32, 100111.Google Scholar
38. Strøm, M, Granström, C, Lyall, K et al. (2017) Research letter: Folic acid supplementation and intake of folate in pregnancy in relation to offspring risk of autism spectrum disorder. Psychol Med 48, 10481054.Google Scholar
39. DeVilbiss, EA, Magnusson, C, Gardner, RM, et al. (2017) Antenatal nutritional supplementation and autism spectrum disorders in the Stockholm youth cohort: population based cohort study. BMJ 4273, j4273.Google Scholar
40. Zhou, J, Liu, A, He, F et al. (2018) High prevalence of serum folate receptor autoantibodies in children with autism spectrum disorders. Biomarkers 23, 622624.Google Scholar
41. Steenweg-De-Graaff, J, Roza, SJ, Steegers, EA et al. (2012) Maternal folate status in early pregnancy and child emotional and behavioral problems: the Generation R Study. Am J Clin Nutr 95, 14131421.Google Scholar
42. Veena, SR, Krishnaveni, GV, Srinivasan, K et al. (2010) Higher maternal plasma folate but not vitamin B-12 concentrations during pregnancy are associated with better cognitive function scores in 9–10 year old children in South-India. J Nutr 140, 10141022.Google Scholar
43. Tamura, T, Goldenberg, RL, Chapman, VR et al. (2005) Folate status of mothers during pregnancy and mental and psychomotor development of their children at five years of age. Pediatrics 116, 703708.Google Scholar
44. Glover, V (2018) Stress in pregnancy can change fetal and child development. In Transforming Infant Wellbeing: Research, Policy and Practice for the First 1001 Critical Days, pp. 98106 [P Leach, editor]. Abingdon: Routledge.Google Scholar
Figure 0

Fig. 1 Flowchart showing the number of participants throughout the study (PreC, preconception; STAI; State-Trait Anxiety Inventory; tHcy, total homocysteine; CBCL/4-18, Child Behaviour Checklist; IOWA, Inattention-Overactivity with Aggression; IQ, intelligence quotient; WPPSI, Wechsler Preschool and Primary Scale of Intelligence)

Figure 1

Table 1 Mother and child characteristics from the preconception to follow-up stage and differences between maternal preconception total homocysteine groups (PreConception Study, pregnancy phase 1992–1996; child follow-up stage 1998–2002. Reus, Spain)

Figure 2

Table 2 Comparison of child psychological problems at age 6 years between maternal preconception total homocysteine groups (PreConception Study, pregnancy phase 1992–1996; child follow-up stage 1998–2002. Reus, Spain)

Figure 3

Table 3 Significant multiple linear regression models of the effect of maternal preconception total homocysteine level on child psychological problems at age 6 years (PreConception Study, pregnancy phase 1992–1996; child follow-up stage 1998–2002. Reus, Spain)